Establishing Effective Diagnostic Criteria for Vulval Lichen Sclerosus in adults: A study to develop risk prediction model and subsequent diagnostic test accuracy study (SHELLS)

Background Vulval lichen sclerosus (LS) is an inflammatory condition affecting predominantly vulval, perineal and perianal skin. It causes distressing symptoms which impact on daily life, and complications include scarring as well as an increased risk of vulval cancer. LS affects an estimated 1 in 100 women. Symptoms and complications can be minimised by effective treatment. LS is often misdiagnosed, leading to delayed diagnosis and treatment. The study objective is to establish the best predictors for vulval LS in adult females and subsequently develop a diagnostic tool to help differentiate from other vulval conditions. Methods Women (≥18 years) referred to UK-based secondary care specialist clinics with a vulval skin complaint are eligible to participate. A diagnosis of LS (cases) or an alternative vulval condition (non-cases) will be made by a clinician experienced in vulval diseases. All participants complete a single research visit on the same day or within two weeks of the initial appointment, for diagnostic criteria assessment by a trained investigator, blinded to diagnosis. This study uses clinical expert diagnosis as the reference standard, and diagnostic criteria assessment as the index test. A sample size of 370 participants (185 cases and 185 non-cases) is needed to aim for a confidence interval of 0.45–0.55 for the overall outcome proportion of 0.5 and to target a mean absolute error of 0.062 between observed and true outcome probabilities. Sensitivity and specificity of each of the diagnostic criteria will be calculated. Recruitment target of 407 participants will include a 10% increase for missing data. Ethics and dissemination National Health Service Research Ethics Committee approvals were granted in May 2024 (REC 24/LO/0290) by London – Camberwell St Giles Research Ethics Committee. The protocol was prospectively registered on 17.06.2024 (ISRCTN76946205). Study results will be widely disseminated through publication, presentations at international academic meetings and via social media, plus patient associations. Study registration number: ISRCTN76946205.

Authors

Institutions

Publication Details

Journal
NIHR Open Research
Published
2026-11-20
DOI
https://doi.org/10.3310/nihropenres.14295.1
Primary Topic
Genital Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Establishing Effective Diagnostic Criteria for Vulval Lichen Sclerosus in adults: A study to develop risk prediction model and subsequent diagnostic test accuracy study (SHELLS)

Kim Suzanne Thomas, Sonia Gran, JANE P. DANIELS, Gudula Kirtschig et al.
3 links
NIHR Open Research
Genital Health and Disease
article

Establishing Effective Diagnostic Criteria for Vulval Lichen Sclerosus in adults: A study to develop risk prediction model and subsequent diagnostic test accuracy study (SHELLS)

Kim Suzanne Thomas, Sonia Gran, JANE P. DANIELS, Gudula Kirtschig, Esther Burden‐Teh, Rosalind C. Simpson, Rheanne Leatherland
article en

Abstract

Background Vulval lichen sclerosus (LS) is an inflammatory condition affecting predominantly vulval, perineal and perianal skin. It causes distressing symptoms which impact on daily life, and complications include scarring as well as an increased risk of vulval cancer. LS affects an estimated 1 in 100 women. Symptoms and complications can be minimised by effective treatment. LS is often misdiagnosed, leading to delayed diagnosis and treatment. The study objective is to establish the best predictors for vulval LS in adult females and subsequently develop a diagnostic tool to help differentiate from other vulval conditions. Methods Women (≥18 years) referred to UK-based secondary care specialist clinics with a vulval skin complaint are eligible to participate. A diagnosis of LS (cases) or an alternative vulval condition (non-cases) will be made by a clinician experienced in vulval diseases. All participants complete a single research visit on the same day or within two weeks of the initial appointment, for diagnostic criteria assessment by a trained investigator, blinded to diagnosis. This study uses clinical expert diagnosis as the reference standard, and diagnostic criteria assessment as the index test. A sample size of 370 participants (185 cases and 185 non-cases) is needed to aim for a confidence interval of 0.45–0.55 for the overall outcome proportion of 0.5 and to target a mean absolute error of 0.062 between observed and true outcome probabilities. Sensitivity and specificity of each of the diagnostic criteria will be calculated. Recruitment target of 407 participants will include a 10% increase for missing data. Ethics and dissemination National Health Service Research Ethics Committee approvals were granted in May 2024 (REC 24/LO/0290) by London – Camberwell St Giles Research Ethics Committee. The protocol was prospectively registered on 17.06.2024 (ISRCTN76946205). Study results will be widely disseminated through publication, presentations at international academic meetings and via social media, plus patient associations. Study registration number: ISRCTN76946205.

NIHR Open ResearchVol. 6
University of Nottingham (GB), Medbase (CH)
Good health and well-being
Genital Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon